Xeris Pharmaceuticals | XERS - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
Celltrion KRW 1.51T 128.69B 2025-09
Cspc Pharmaceutical CNY 8.85B 769.12M 2025-06
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Nektar Therapeutics USD 0 2.9M 2024-09
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 49.94M 14.92M 2025-12
Ovoca Bio EUR 447K 113K 2022-06
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pharma Mar EUR 60.6M 18.83M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Sartorius EUR 344.7M 48.5M 2025-09
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.12B 222.78M 2025-09